ACE2 Archives - Freedom Wares

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

Molecular Modeling Targeting the ACE2 Receptor with Cannabis sativa’s Active Ingredients for Antiviral Drug Discovery against SARS-CoV-2 Infections

Journal List Bioinform Biol Insights v.16; 2022 PMC9793058 Bioinform Biol Insights. 2022; 16: 11779322221145380. Published online…

Freedom WaresDecember 23, 2022

Canna~Fangled Abstracts

In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery

Future Virol. 2022 Mar;0(0). doi: 10.2217/fvl-2021-0309. Epub 2022 Apr 4. Amira R Khattab 1, Mohamed Teleb 2 Affiliations expand PMID: 35399958…

Freedom WaresApril 4, 2022

Canna~Fangled Abstracts

Cannabidiol and SARS-CoV-2 Infection

Front Immunol. 2022 Mar 24;13:870787. doi: 10.3389/fimmu.2022.870787. eCollection 2022. Alexandre Vallée 1 Affiliations expand PMID: 35401543 PMCID: PMC8987006 DOI: 10.3389/fimmu.2022.870787 Abstract…

Freedom WaresMarch 24, 2022

Canna~Fangled Abstracts

New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts

Cell Death Discov. 2022 Mar 11;8(1):110. doi: 10.1038/s41420-022-00876-y. Bo Wang 1 2, Dongping Li 1 2, Anna Fiselier 1 2 3 4, Igor Kovalchuk 5 6 7, Olga Kovalchuk 8 9 10 Affiliations expand…

Freedom WaresMarch 11, 2022

Canna~Fangled Abstracts

Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19

Preclinical studies have demonstrated its effectiveness against diseases of the respiratory system as well as…

Freedom WaresFebruary 17, 2021

ACE2

Molecular Modeling Targeting the ACE2 Receptor with Cannabis sativa’s Active Ingredients for Antiviral Drug Discovery against SARS-CoV-2 Infections

In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery

Cannabidiol and SARS-CoV-2 Infection

New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts

Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19

Recent Posts

Archives

Categories